Bessemer Group Inc. Purchases 23,380 Shares of UFP Technologies, Inc. (NASDAQ:UFPT)

Bessemer Group Inc. raised its position in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) by 22.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 129,209 shares of the industrial products company's stock after purchasing an additional 23,380 shares during the period. Bessemer Group Inc. owned approximately 1.68% of UFP Technologies worth $31,592,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of UFPT. Boston Trust Walden Corp bought a new stake in shares of UFP Technologies in the 4th quarter valued at $26,395,000. Raymond James Financial Inc. bought a new stake in shares of UFP Technologies in the fourth quarter worth about $16,808,000. Franklin Resources Inc. raised its position in shares of UFP Technologies by 48.1% during the fourth quarter. Franklin Resources Inc. now owns 136,345 shares of the industrial products company's stock worth $33,338,000 after purchasing an additional 44,292 shares during the period. Congress Asset Management Co. lifted its holdings in shares of UFP Technologies by 14.2% during the 4th quarter. Congress Asset Management Co. now owns 281,325 shares of the industrial products company's stock valued at $68,787,000 after purchasing an additional 35,022 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its holdings in shares of UFP Technologies by 340.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 39,304 shares of the industrial products company's stock valued at $9,610,000 after purchasing an additional 30,372 shares in the last quarter. 87.28% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Raymond James assumed coverage on UFP Technologies in a research note on Friday, March 28th. They set a "market perform" rating for the company. StockNews.com downgraded shares of UFP Technologies from a "hold" rating to a "sell" rating in a research report on Thursday, January 23rd.

Insider Activity at UFP Technologies

In other UFP Technologies news, Director Daniel C. Croteau sold 6,846 shares of the firm's stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $228.41, for a total value of $1,563,694.86. Following the completion of the transaction, the director now directly owns 1,785 shares in the company, valued at $407,711.85. This trade represents a 79.32 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 6.17% of the stock is owned by insiders.

UFP Technologies Stock Down 3.4 %

Shares of UFPT stock traded down $7.13 on Tuesday, hitting $201.30. 42,964 shares of the stock were exchanged, compared to its average volume of 78,402. The company has a current ratio of 2.57, a quick ratio of 1.43 and a debt-to-equity ratio of 0.64. The firm has a market capitalization of $1.55 billion, a P/E ratio of 28.72 and a beta of 1.08. UFP Technologies, Inc. has a fifty-two week low of $178.26 and a fifty-two week high of $366.41. The business has a 50-day moving average of $223.42 and a 200 day moving average of $262.09.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The industrial products company reported $2.46 earnings per share for the quarter, topping analysts' consensus estimates of $2.01 by $0.45. UFP Technologies had a return on equity of 18.92% and a net margin of 11.74%. The firm had revenue of $144.07 million during the quarter, compared to the consensus estimate of $141.67 million.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.